Cardinal Health, Inc. (CAH)
| Market Cap | 51.83B +66.2% |
| Revenue (ttm) | 244.67B +10.1% |
| Net Income | 1.66B +26.7% |
| EPS | 6.94 +29.5% |
| Shares Out | 235.32M |
| PE Ratio | 31.72 |
| Forward PE | 20.50 |
| Dividend | $2.04 (0.93%) |
| Ex-Dividend Date | Jan 2, 2026 |
| Volume | 1,440,295 |
| Open | 226.00 |
| Previous Close | 225.76 |
| Day's Range | 219.58 - 227.05 |
| 52-Week Range | 120.72 - 230.81 |
| Beta | 0.66 |
| Analysts | Buy |
| Price Target | 229.09 (+4.0%) |
| Earnings Date | Feb 5, 2026 |
About CAH
Cardinal Health, Inc. operates as a healthcare services and products company in the United States and internationally. It operates in two segments: Pharmaceutical and Specialty Solutions, and Global Medical Products and Distribution. The company provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home. It distributes branded and generic pharmaceutical, specialty pharmaceutical, and over-the-counter healthcare and consumer products.... [Read more]
Financial Performance
In fiscal year 2025, Cardinal Health's revenue was $222.58 billion, a decrease of -1.87% compared to the previous year's $226.83 billion. Earnings were $1.56 billion, an increase of 83.22%.
Financial StatementsAnalyst Summary
According to 11 analysts, the average rating for CAH stock is "Buy." The 12-month stock price target is $229.09, which is an increase of 4.00% from the latest price.
News
Cardinal Health Q2 2026 Review: An Epitome Of Resilience And Earnings Power (Upgrade)
Cardinal Health is upgraded to a buy after Q2 2026 delivered robust revenue, margin expansion, and raised full-year guidance. Q2 revenue grew 19% YoY to $65.6B, with non-GAAP EPS up 36% and broad-base...
Cardinal Health Stock Roars Higher. Another Guidance Boost Can Do That.
The pharmaceutical distributor and health services company raises its guidance for the second time.
Cardinal Health, Inc. (CAH) Q2 2026 Earnings Call Transcript
Cardinal Health, Inc. (CAH) Q2 2026 Earnings Call Transcript
Cardinal Health boosts annual profit forecast banking on surging demand for specialty drugs
Cardinal Health on Thursday raised its expectations for annual profit after surpassing Wall Street estimates for quarterly results, as it bets on robust demand for specialty medicines and strong perfo...
Cardinal Health Lifts Outlook After Posting Higher Profit
Cardinal Health raised its outlook for the year after logging higher profit and revenue in its fiscal second quarter.
Cardinal Health Reports Second Quarter Fiscal Year 2026 Results and Raises Outlook
Revenue increased 19% to $65.6 billion GAAP 1 operating earnings increased 29% to $707 million; GAAP diluted EPS increased 19% to $1.97 Non-GAAP operating earnings increased 38% to $877 million; non-G...
Cardinal Health Upgraded As It Maintains Investment-Grade Status And Position In Radiopharmaceuticals
Cardinal Health gets upgraded to a buy, despite its price having gone up over 100% since my bullish call in early 2024. CAH could benefit from longer-term macro demand for medical supplies, mitigating...
Cardinal Health, Inc. (CAH) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
Cardinal Health, Inc. (CAH) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
Cardinal Health Stock Jumps on Guidance Raise. Why 2026 Will Be a Good Year.
The healthcare services company says it expects to bring in over $50 billion in specialty revenue in fiscal 2026.
Cardinal Health raises 2026 profit forecast
Cardinal Health on Tuesday forecast 2026 adjusted profit to be at least $10 per share, compared with its prior projection of $9.65 to $9.85 per share.
Cardinal Health Raises Fiscal 2026 Outlook and Highlights Strategic Progress During J.P. Morgan Healthcare Conference Presentation
Raising Fiscal 2026 Outlook: Cardinal Health is increasing expectations for fiscal year 2026 non-GAAP diluted earnings per share (EPS)1 to at least $10.00, from its prior guidance range of $9.65 to $9...
Cardinal Health to Announce Second-Quarter Results for Fiscal Year 2026 on February 5
DUBLIN, Ohio, Jan. 6, 2026 /PRNewswire/ -- Cardinal Health (NYSE: CAH) plans to release second-quarter financial results for its fiscal year 2026 on February 5, prior to the opening of trading on the ...
These Healthcare and Bank Stocks Had Incredible Runs in 2025. Why Gains Will Continue This Year.
With a 58% gain, CVS Health had its best year since 1982—and it wasn't the only strong performer.
Best Dividend Aristocrats For January 2026
The ProShares S&P 500 Dividend Aristocrat ETF (NOBL) underperformed SPY in 2025, gaining 7.2% versus SPY's 18.42%. Despite average underperformance, select Aristocrats like CAH (+74.18%), ALB (+66.90%...
Dividend Income: Lanny's October 2025 Summary
In October, we (my wife and I) received a dividend income total of $3,948.78. Crushing it for an off-month – thanks to Vanguard (VOO) and Fidelity (FXAIX) for paying in October. We had quite a few div...
Cardinal Health, Inc. (CAH) Presents at Citi Annual Global Healthcare Conference 2025 Transcript
Cardinal Health, Inc. (CAH) Presents at Citi Annual Global Healthcare Conference 2025 Transcript
Cardinal Health, Inc. (CAH) Presents at Evercore 8th Annual Healthcare Conference Transcript
Cardinal Health, Inc. (CAH) Presents at Evercore 8th Annual Healthcare Conference Transcript
Potentially 12%-15% Consistent Income: Monthly Options Series (December 2025)
Selling options can generate 12-15% annual income but requires discipline, risk management, and due diligence. We explain why selling cash-covered puts and covered calls is a relatively safe choice fo...
Best Dividend Aristocrats For December 2025
The ProShares S&P 500 Dividend Aristocrats ETF (NOBL) has underperformed the SPDR S&P 500 ETF (SPY) year-to-date, but November shows a reversal. Several Dividend Aristocrats, including CAH, CAT, CHRW,...
6 Healthcare Stocks With Strong Upward Momentum
Out with the old (tech), in with the new (healthcare). After several volatile weeks, it appears a full-fledged rotation has begun with investors fleeing previously high-flying tech winners in favor of...
Cardinal Health, Inc. (CAH) Presents at UBS Global Healthcare Conference 2025 Transcript
Cardinal Health, Inc. ( CAH) UBS Global Healthcare Conference 2025 November 11, 2025 8:45 AM EST Company Participants Matt Sims - Vice President of Investor Relations Aaron Alt - Chief Financial Offi...
Cardinal Health: Quiet Transformation, Clear Buy
Cardinal Health (CAH) is evolving into a specialty-focused healthcare leader, leveraging acquisitions and managed services for higher profitability and efficiency. CAH's financials show strong gross p...
Increasing medication access: Charitable clinics and pharmacies to receive share in $1.6 million in Equity Rx grants from Cardinal Health Foundation
Grants are a part of $5 million commitment from Cardinal Health Foundation and awarded by the National Association of Free & Charitable Clinics Grants are a part of $5 million commitment from Cardinal...
Cardinal Health Board of Directors Approves Quarterly Dividend
DUBLIN, Ohio , Nov. 4, 2025 /PRNewswire/ -- Cardinal Health (NYSE: CAH) announced today that its Board of Directors approved its quarterly dividend of $0.5107 per share, out of the Company's capital s...
Cardinal Health completes acquisition of Solaris Health
Adds the country's leading urology MSO with over 750 providers to Cardinal Health's leading multi-specialty MSO platform, The Specialty Alliance and brings Cardinal Health's MSO platforms to ~3,000 pr...